These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12175635)

  • 21. Hepatitis B vaccination in diabetic patients. Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen.
    Douvin C; Simon D; Charles MA; Deforges L; Bierling P; Lehner V; Budkowska A; Dhumeaux D
    Diabetes Care; 1997 Feb; 20(2):148-51. PubMed ID: 9118762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-DRB1*1301 and *1302 protect against chronic hepatitis B.
    Höhler T; Gerken G; Notghi A; Lubjuhn R; Taheri H; Protzer U; Löhr HF; Schneider PM; Meyer zum Büschenfelde KH; Rittner C
    J Hepatol; 1997 Mar; 26(3):503-7. PubMed ID: 9075656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-HBs persistence following revaccination with three doses of hepatitis B vaccine among low-responsive adults after primary vaccination: a 4-year follow-up study].
    Lyu JJ; Yin XW; Yan BY; Liu JY; Feng Y; Wu WL; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang L; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):491-6. PubMed ID: 27256727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C4A and C4B null alleles are genetic markers of different types of systemic sclerosis in Japanese patients.
    Takeuchi F; Nabeta H; Hong GH; Matsuta K; Tokunaga K; Tanimoto K; Nakano K
    Clin Exp Rheumatol; 1998; 16(1):55-60. PubMed ID: 9543562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy of hepatitis B vaccination program in upper Egypt: Flow cytometry and the evaluation of long term immunogenicity.
    Makhlouf NA; Farghaly AM; Zaky S; Rashed HA; Abu Faddan NH; Sayed D; El-Badawy O; Afifi N; Hamza WS; El-Sayed Y
    J Med Virol; 2016 Sep; 88(9):1567-75. PubMed ID: 26910304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of G protein beta3 subunit C825T and HLA class II polymorphisms in the immune response after HBV vaccination.
    Lindemann M; Barsegian V; Siffert W; Ferencik S; Roggendorf M; Grosse-Wilde H
    Virology; 2002 Jun; 297(2):245-52. PubMed ID: 12083823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody level after hepatitis B vaccination in hemodialysis patients: influence of hepatitis C virus infection.
    Navarro JF; Teruel JL; Mateos ML; Marcen R; Ortuno J
    Am J Nephrol; 1996; 16(2):95-7. PubMed ID: 8919223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
    Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
    Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination.
    Lin HH; Liao HW; Lin SK; Wang LY
    Vaccine; 2008 Jun; 26(27-28):3414-20. PubMed ID: 18501999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C.
    Wiedmann M; Liebert UG; Oesen U; Porst H; Wiese M; Schroeder S; Halm U; Mössner J; Berr F
    Hepatology; 2000 Jan; 31(1):230-4. PubMed ID: 10613751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic regulation of the impaired immune response to hepatitis-B vaccine associated with low TCR density in end stage renal disease patients: contribution of complement C4 and factor B alleles.
    Kramer J; Stachowski J; Barth C; Ujhelyi E; Tarján V; Sulowicz W; Füst G; Baldamus CA
    Immunol Lett; 1997 Oct; 59(1):13-9. PubMed ID: 9334852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis the relation of adults HBV vicinal failure and T cell subset, HLA-DR rang gene phenotype].
    Hu DB; Liu SK; Zhao LL; Xu AP; Hong YZ; Cao PY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb; 23(1):17-9. PubMed ID: 19799007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonresponse to hepatitis B vaccines and the kinetics of anti-HBs production.
    Zuckerman JN
    J Med Virol; 1996 Dec; 50(4):283-8. PubMed ID: 8950683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study of the genetic basis of C4A protein deficiency. Detection of C4A gene deletion by long-range PCR and its associated haplotypes.
    Kristjánsdóttir H; Steinsson K
    Scand J Rheumatol; 2004; 33(6):417-22. PubMed ID: 15794202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Is it necessary to revaccinate against hepatitis B virus when the titer of anti-HBs drops below 10 IU/L?].
    Polák P; Husa P; Smejkal P; Kamelander J; Chlupová G; Penka M
    Klin Mikrobiol Infekc Lek; 2016 Sep; 22(3):125-130. PubMed ID: 27907975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The involvement of HLA -DRB1*, DQA1*, DQB1* and complement C4A loci in diagnosing systemic lupus erythematosus among Tunisians.
    Ayed K; Gorgi Y; Ayed-Jendoubi S; Bardi R
    Ann Saudi Med; 2004; 24(1):31-5. PubMed ID: 15310011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
    Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
    Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases.
    Belle A; Baumann C; Bigard MA; Zallot C; Gizard E; Guéant JL; Bronowicki JP; Peyrin-Biroulet L
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):877-81. PubMed ID: 26121376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.